Navigation Links
Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
Date:5/16/2013

SANTA BARBARA, Calif., May 16, 2013 /PRNewswire-iReach/ -- Active Life Scientific, Inc., a life science research and diagnostic tools company, today announced a $500K Follow On Series A round of financing. The round was filled by new and existing investors, including follow on investment by members of Tech Coast Angels, the largest angel investment group in the country.

Active Life is developing next generation medical tools to cost effectively address the growing problem of degenerating and stiffening tissues - a leading cause of frailty.  The company's technology, Reference Point Indentation (RPI), is the latest breakthrough from world-renowned inventor Dr. Paul Hansma .  Active Life's products are currently being sold to scientists and are under development for physicians to directly measure tissue physical properties inside a living body.  Previous to RPI, similar tests required an invasive biopsy and destructive testing in an advanced laboratory, and as a result were rarely performed.

"Tech Coast Angels are confident in our reinvestment into Active Life and the vast potential of the Company," stated Mike Panesis , Vice Chair of the Tech Coast Angels (TCA) and President of TCA's Central Coast Network. "The platform nature of their technology is extremely interesting. The technology fills important needs in numerous markets including life science, medicine, animal science, consumer products, and more."

"Modern medicine is successfully extending the duration of life to new levels.  At Active Life, we are focused on extending and improving quality of life," stated Davis Brimer , Active Life's Chief Executive Officer.  "We are honored to pursue this goal with the support of top-notch, sophisticated investors."

About Active Life

Active Life Scientific, Inc. develops life science research and diagnostic tools with previously impossible ability to quantify physical properties of tissues without the need for an invasive biopsy.   Frailty and diseases linked to degenerating or stiffening tissues, or tissue physical properties, are currently assessed using surrogate endpoints.  Active Life's Reference Point Indentation introduces an unrivaled direct, in vivo measure of tissue physical properties.  The Company's products are based on world renowned inventor Dr. Paul Hansma 's latest breakthrough, Reference Point Indentation.

About Tech Coast Angels

Tech Coast Angels is an angel investor network in the United States and one of the leading sources of funding to early-stage companies in Southern California.  Since its inception in 1997, TCA members have focused on building valuable companies, personally invested nearly $119 million and helped portfolio companies attract more than $1.4 billion in additional capital, mostly from venture capital firms.  TCA members give companies more than just capital; they also provide counsel, mentoring and access to an extensive network of potential investors, customers, strategic partners and management talent.  TCA has more than 250 members, including its venture capital affiliates, in five networks in Los Angeles, Orange County, San Diego, Westlake/Santa Barbara, and the Inland Empire.

Media Contact: Davis Brimer , Active Life Scientific, Inc., +1.805.770.2600 x101, davis@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Warm Weather Means Active Children May Be Prone To More Injuries
2. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
3. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
4. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
5. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
6. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
7. United Seating & Mobility Completes Acquisition of Active American Mobility
8. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
9. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
10. EJK Duisburg Becomes One of the Most Active SynCardia Certified Centers in Europe
11. How to Create Dynamic Interactive Social Learning Spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Calif. , Oct. 11, 2017  BioPharmX Corporation ... scientific team that developed an innovative way to use ... of the delivery of new drugs. ... Fall Clinical Dermatology Conference will show how researchers from ... Hospital, Harvard Medical School used a suite of imaging ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... COUNTY, Calif. , Oct. 10, 2017  NDS received FDA ... Mobile  — a medical-grade battery-powered display stand specifically designed for endoscopy ... to transform technology into a clinical solution to support the improvement ... Innovative Design ... ZeroWire Mobile Wireless Solution ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
Breaking Medicine News(10 mins):